FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis

This designation advances the management of acute infections and sepsis by empowering clinicians with timely insights for better patient...
1 week ago
from: Business Wire

Food and Drug Administration, Medicine, Sepsis

More about this

- FDA grants breakthrough device designation to MeMed sepsis test
The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to MeMed for its rapid diagnostic and risk...
from: LabPulse.com

- MeMed’s Severity Test for Suspected Sepsis Gains FDA Breakthrough Status
The Severity test measures multiple proteins from a blood sample and leverages machine learning to stratify risk of patient deterioration.
from: Medical Product Outsourcing